Published in BMC Infect Dis on September 12, 2014
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol (2016) 0.85
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83
Associations Between the Phosphatidylethanol Alcohol Biomarker and Self-Reported Alcohol Use in a Sample of HIV-Infected Outpatient Drinkers in Western Kenya. Alcohol Clin Exp Res (2016) 0.78
The role of alcohol use in antiretroviral adherence among individuals living with HIV in South Africa: Event-level findings from a daily diary study. Drug Alcohol Depend (2016) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med (2002) 24.22
The MOS social support survey. Soc Sci Med (1991) 23.60
Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev (2007) 10.34
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85
Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction (2002) 5.45
The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer (1984) 5.24
Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addict (1992) 5.02
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr (2006) 4.81
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr (2002) 4.39
Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav (2007) 4.07
Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr (2009) 3.88
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials (2004) 3.75
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr (2009) 3.67
Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res (1997) 3.16
Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr (2006) 2.78
Motivational interviewing for substance abuse. Cochrane Database Syst Rev (2011) 2.39
Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr (2007) 2.38
Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res (2005) 2.29
Causal considerations on alcohol and HIV/AIDS--a systematic review. Alcohol Alcohol (2010) 2.22
The efficacy of problem solving therapy in reducing mental and physical health problems: a meta-analysis. Clin Psychol Rev (2006) 2.18
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS (2008) 2.14
Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care (2007) 2.06
The role of self-efficacy in HIV treatment adherence: validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). J Behav Med (2007) 1.98
Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs (2009) 1.94
Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa. Curr HIV/AIDS Rep (2011) 1.88
Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses (2010) 1.85
A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther (2005) 1.82
Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep (2010) 1.64
Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth. AIDS Educ Prev (2006) 1.62
Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDS (2009) 1.56
Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward. Glob Public Health (2011) 1.55
Preventing HIV transmission in married and cohabiting HIV-discordant couples in sub-Saharan Africa through combination prevention. Curr HIV Res (2010) 1.42
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41
The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence. Can J Psychiatry (2012) 1.40
The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy. AIDS Care (2006) 1.39
Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction (2013) 1.38
Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs. J Gen Intern Med (2012) 1.33
Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res (2011) 1.33
The temporal relationship between alcohol consumption and HIV-medication adherence: a multilevel model of direct and moderating effects. Health Psychol (2008) 1.27
Screening for alcohol and drug use disorders among adults in primary care: a review. Subst Abuse Rehabil (2012) 1.26
Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis (1993) 1.23
Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms. J Infect Dis (1996) 1.19
Alcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV. J Assoc Nurses AIDS Care (2012) 1.19
Alcohol's role in HIV transmission and disease progression. Alcohol Res Health (2010) 1.17
Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis. Int J Mol Sci (2012) 1.13
Brief report: maintenance of effects of motivational enhancement therapy to improve risk behaviors and HIV-related Health in a randomized controlled trial of youth living with HIV. J Pediatr Psychol (2007) 1.02
Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective. BMC Public Health (2012) 0.95
Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS (1996) 0.94
Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus. Patient Prefer Adherence (2014) 0.91
HIV-1 infection in peripheral blood lymphocytes (PBLs) exposed to alcohol. Virology (2003) 0.90
The effectiveness of problem solving therapy in deprived South African communities: results from a pilot study. BMC Psychiatry (2011) 0.90
Associations between alcohol use, other psychosocial factors, structural factors and antiretroviral therapy (ART) adherence among South African ART recipients. AIDS Behav (2014) 0.89
Adapting a blended motivational interviewing and problem-solving intervention to address risky substance use amongst South Africans. Psychother Res (2014) 0.89
Problem solving styles among people who use alcohol and other drugs in South Africa. Addict Behav (2013) 0.81
Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment. J Subst Abuse Treat (2010) 0.81
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
Alcohol and public health. Lancet (2005) 10.82
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 7.93
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00
Short-course antiretroviral therapy in primary HIV infection. N Engl J Med (2013) 4.82
Risky single-occasion drinking: bingeing is not bingeing. Addiction (2010) 4.63
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90
The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction (2012) 3.74
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ (2010) 3.31
The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol (2013) 3.23
Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health (2003) 3.03
Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care (2009) 3.03
Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr (2009) 2.99
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis (2009) 2.82
Microbicide acceptability research: current approaches and future directions. Soc Sci Med (2005) 2.54
Substance use, sexual risk, and violence: HIV prevention intervention with sex workers in Pretoria. AIDS Behav (2006) 2.52
Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol (2010) 2.49
Are the 1976-1985 birth cohorts heavier drinkers? Age-period-cohort analyses of the National Alcohol Surveys 1979-2010. Addiction (2012) 2.42
Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health (2010) 2.42
Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol (2004) 2.38
Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav (2009) 2.33
Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis (2004) 2.33
Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis (2004) 2.29
Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health (2009) 2.23
Causal considerations on alcohol and HIV/AIDS--a systematic review. Alcohol Alcohol (2010) 2.22
Changes in illicit opioid use across Canada. CMAJ (2006) 2.20
Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry (2006) 2.16
Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr (2006) 2.12
Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism. Addiction (2009) 2.06
Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction (2012) 2.04
Age, period and cohort influences on beer, wine and spirits consumption trends in the US National Alcohol Surveys. Addiction (2004) 2.01
The burden of cancer attributable to alcohol drinking. Int J Cancer (2006) 2.01
Age-period-cohort modelling of alcohol volume and heavy drinking days in the US National Alcohol Surveys: divergence in younger and older adult trends. Addiction (2009) 1.98
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J Virol (2002) 1.97
Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ (2011) 1.94
Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction (2011) 1.93
Multicentre study of acute alcohol use and non-fatal injuries: data from the WHO collaborative study on alcohol and injuries. Bull World Health Organ (2006) 1.90
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol (2007) 1.89
Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. Lancet Infect Dis (2002) 1.88
Revolving doors: imprisonment among the homeless and marginally housed population. Am J Public Health (2005) 1.86
How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol (2003) 1.85
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health (2011) 1.81
Effects of depression and social integration on the relationship between alcohol consumption and all-cause mortality. Addiction (2002) 1.78
Harmful alcohol use. Alcohol Res Health (2003) 1.74
Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia (2010) 1.73
Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health (2005) 1.73
Use of other opioids during methadone therapy: a population-based study. Addiction (2012) 1.72
Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend (2007) 1.71
Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend (2005) 1.71
Detecting small-area similarities in the epidemiology of childhood acute lymphoblastic leukemia and diabetes mellitus, type 1: a Bayesian approach. Am J Epidemiol (2005) 1.71
Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf (2011) 1.69
Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel. AIDS Behav (2011) 1.68
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res Hum Retroviruses (2003) 1.68
Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction (2002) 1.67
Linkage to HIV care and survival following inpatient HIV counseling and testing. AIDS Behav (2011) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Trends in adolescent alcohol and other drug use: findings from three sentinel sites in South Africa (1997-2001). J Adolesc (2004) 1.65
Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol (2012) 1.63
The burden of death, disease, and disability due to alcohol in New Zealand. N Z Med J (2005) 1.61
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev (2003) 1.57
Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP (2009) 1.57
Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol (2008) 1.56
Barriers to mental health care and predictors of treatment dropout in the South African Stress and Health Study. Psychiatr Serv (2011) 1.56
Multi-level analysis of alcohol-related injury among emergency department patients: a cross-national study. Addiction (2005) 1.53
Sexual risk behaviour among HIV-positive individuals in clinical care in urban KwaZulu-Natal, South Africa. AIDS (2006) 1.52
Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend (2006) 1.52
Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend (2006) 1.51
Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda. PLoS One (2011) 1.50
Characteristics of women undergoing repeat induced abortion. CMAJ (2005) 1.50
Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav (2011) 1.49
Predictors of drug use among South African adolescents. J Adolesc Health (2006) 1.49
International regulation of alcohol. BMJ (2008) 1.48
Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction (2013) 1.48
Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health (2013) 1.46
Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction (2006) 1.45
Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ (2004) 1.44
Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Am J Public Health (2003) 1.43
Average volume of alcohol consumption and all-cause mortality in African Americans: the NHEFS cohort. Alcohol Clin Exp Res (2003) 1.42
Understanding the parameters of non-medical use of prescription drugs: moving beyond mere numbers. Addiction (2007) 1.42
Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. Can J Public Health (2008) 1.41
Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS (2012) 1.41
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence. Can J Psychiatry (2012) 1.40
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40
Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr (2002) 1.40
The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample. AIDS Behav (2007) 1.39
Does the association between alcohol consumption and depression depend on how they are measured? Alcohol Clin Exp Res (2007) 1.38
Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil (2010) 1.38
Difficulties with telephone-based surveys on alcohol consumption in high-income countries: the Canadian example. Int J Methods Psychiatr Res (2012) 1.34
Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035. J Acquir Immune Defic Syndr (2013) 1.33
Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study. J Acquir Immune Defic Syndr (2008) 1.33